Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Eli Lilly studies LY-3375880 in phase II trial for moderate to severe atopic dermatitis

March 8, 2019

Exosome therapy for hair loss shows promise

March 8, 2019

Serum CIRP as novel biomarker for monitoring disease activity in alopecia areata

March 8, 2019

DS Biopharma reports promising data on DS-107 cream in moderate to severe atopic dermatitis

March 7, 2019

Allergan divulges CCR-6 antagonists

March 6, 2019

Mirikizumab maintains response and safety in phase II study in patients with psoriasis

March 6, 2019

Processa Pharmaceuticals reports preliminary safety data for PCS-499

March 6, 2019

Phase III data presented for trifarotene in patients with facial and truncal acne

March 6, 2019

New phase Ib trial explores use of AVID-200 in diffuse cutaneous systemic sclerosis

March 5, 2019

BirchBioMed initiates proof-of-concept study with FS-2 to reduce keloid scars

March 4, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...